Sun Pharma commences tender offer for acquisition of InSite Vision
The tender offer will expire on October 27, 2015, at 12:00 midnight New York City time Sun Pharmaceutical Industries has…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sun Pharmaceutical Industries
Strides Arcolab acquires CNS divisions of erstwhile Ranbaxy
The agreement involves transfer of Ranbaxy’s Solus and Solus Care divisions, along with employees to Strides for a consideration…
Sun Pharma to acquire InSite Vision
Strengthens branded ophthalmic portfolio in US Sun Pharmaceutical Industries' subsidiary has entered into an agreement and plan…
Sun Pharma, Wockhardt recall drugs from US market
Sun Pharma’s recall was initiated last month under Class-III classification while Wockhardt's recall was under class-II…
Sun Pharma in distribution agreement with AstraZeneca for brand Axcer
Sun Pharma will be promoting and distributing Axcer brand in India AstraZeneca Pharma India Limited (AZPIL) and Sun Pharma have…
Sun Pharma closes merger deal with Ranbaxy
The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations
Biocon, Sun Pharma awarded for innovation
Study shows high tech engineering, pharma as front runners of innovation in India
CCI approves Ranbaxy acquisition by Sun Pharma
Sun Pharma and Ranbaxy had filed the notice with the CCI on May 6, 2014 and sought its approval with respect to the deal